The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
CLINICAL PRESENTATION AND OUTCOME OF TUBERCULOSIS IN KIDNEY, LIVER, AND HEART TRANSPLANT RECIPIENTS IN SPAIN1
Abstract
BACKGROUND: Tuberculosis is unusual in transplant recipients. The incidence, clinical manifestations, and optimal treatment of this disease in this population has not been adequately defined. The present study was undertaken to assess the incidence, clinical features, and response to therapy of Mycobacterium tuberculosis infection in solid-organ transplant recipients. METHODS: We evaluated retrospectively the incidence, clinical characteristics, diagnostic procedures, antituberculous treatment, clinical course, and factors influencing mortality in 51 solid-organ transplant recipients who developed tuberculosis after transplantation. We also reviewed the world literature on tuberculosis in solid-organ transplantation. RESULTS: The overall incidence of tuberculosis was 0.8%. The localization was pulmonary in 63% of the cases, disseminated in 25%, and extrapulmonary in 12%. Tuberculosis developed from 15 days to 13 years after surgery (mean, 23 months). In one third of the cases, diagnosis was not suspected initially, and in three cases, diagnosis was made at necropsy. Fever was the most frequent symptom, followed by constitutional symptoms, cough, respiratory insufficiency, and pleuritic pain. Fifteen patients (33%) developed hepatotoxicity during treatment; hepatotoxicity was severe in seven cases. Hepatotoxicity was higher in patients receiving four or more antituberculous drugs (50%) than in patients receiving three drugs (21%; P=0.03). Serum levels of cyclosporine decreased in the 26 patients under the simultaneous use of rifampin. Nine of them (35%) developed acute rejection, and five (56%) died, in comparison with 3 of 17 patients (18%) who did not develop rejection after the use of cyclosporine and rifampin (P=0.03). Although microbiological response was favorable in 94% of the 35 patients who completed 6 or more months of treatment, 16 other patients (31%) died before diagnosis or in the course of treatment. None of the patients treated for more than 9 months died as a consequence of tuberculosis, whereas the mortality rate was 33% among those treated for 6 to 9 months (P=0.03). Use of antilymphocyte antibodies or high doses of steroids for acute rejection before tuberculosis was associated with a higher mortality rate. CONCLUSIONS: M tuberculosis causes serious and potentially life-threatening disease in solid-organ transplant recipients. Treatment with at least three drugs during 9 months or more, avoiding the use of rifampin, appears to be appropriate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
J Heart Lung Transplant 2021;40(4).
(2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.002 · Cited by 6,665
(1964) · The Lancet · doi:10.1016/s0140-6736(64)90527-6 · Cited by 370
THE HIGH INCIDENCE OF TUBERCULOSIS AMONG RENAL TRANSPLANT RECIPIENTS IN INDIA
Sakhuja, V., Jha, V., Varma, P. P., Joshi, K., & Chugh, K. S. (1996) · Transplantation · doi:10.1097/00007890-199601270-00008 · Cited by 186
Transplanted Infections: Donor-to-Host Transmission with the Allograft
Gottesdiener, K. M. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-12-1001 · Cited by 176
Mycobacterial Infection After Renal Transplantation--Report of 14 Cases and Review of the Literature
Qunibi, W. Y., Al-sibai, M. B., Taher, S., Harder, E. J., De Vol, E., Al-Furayh, O., & Ginn, H. E. (1990) · QJM · doi:10.1093/qjmed/77.1.1039 · Cited by 168
Lichtenstein, I. H., & MacGregor, R. R. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.2.216 · Cited by 166
Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function
Buffington, G. A. (1976) · JAMA · doi:10.1001/jama.236.17.1958 · Cited by 107
Tuberculosis in Heart Transplant Recipients
Munoz, P., Palomo, J., Munoz, R., Rodriguez-Cretxems, M., Peláez, T., & Bouza, E. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.2.398 · Cited by 94
TUBERCULOSIS IN LIVER TRANSPLANT PATIENTS
Meyers, B. R., Halpern, M., Sheiner, P. A., Mendelson, M. H., Neibart, E., & Miller, C. M. (1994) · Transplantation · doi:10.1097/00007890-199408000-00008 · Cited by 90
Interaction of Rifampin and Glucocorticoids
Buffington, G. A. (1976) · JAMA · doi:10.1001/jama.1976.03270180034016 · Cited by 84
Cited by
Infection in Organ-Transplant Recipients
Fishman, J. A., & Rubin, R. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806113382407 · Cited by 1,622
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
KASISKE, B. L., VAZQUEZ, M. A., HARMON, W. E., BROWN, R. S., DANOVITCH, G. M., GASTON, R. S., ROTH, D., SCANDLING, J. D., & SINGER, G. G. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11suppl_1s1 · Cited by 634
Singh, N., & Paterson, D. L. (1998) · Clinical Infectious Diseases · doi:10.1086/514993 · Cited by 573
Pulmonary Complications of Solid Organ and Hematopoietic Stem Cell Transplantation
Kotloff, R. M., Ahya, V. N., & Crawford, S. W. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200309-1322so · Cited by 365
Mycobacterium tuberculosis Infection in Recipients of Solid Organ Transplants
Munoz, P., Rodriguez, C., & Bouza, E. (2005) · Clinical Infectious Diseases · doi:10.1086/427692 · Cited by 357
Metadata
- Authors
- Aguado, J. M., Herrero, J. A., Gavald??, J., Torre-Cisneros, J., Blanes, M., Ruf??, G., Moreno, A., Gurgu??, M., Hayek, M., & Lumbreras, C.
- Venue
- Transplantation
- Published
- 1997-05
- Volume
- 63
- Issue
- 9
- Pages
- 1278-1286
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2068279177
- Cited by
- 338
- References
- 18
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CLINICAL PRESENTATION AND OUTCOME OF TUBERCULOSIS IN KIDNEY, LIVER, AND HEART TRANSPLANT RECIPIENTS IN SPAIN1. https://app.cochat.ai/papers/10.1097/00007890-199705150-00015
- The paper
- Aguado, J. M., Herrero, J. A., Gavald??, J., Torre-Cisneros, J., Blanes, M., Ruf??, G., Moreno, A., Gurgu??, M., Hayek, M., & Lumbreras, C. (1997). CLINICAL PRESENTATION AND OUTCOME OF TUBERCULOSIS IN KIDNEY, LIVER, AND HEART TRANSPLANT RECIPIENTS IN SPAIN1. Transplantation. https://doi.org/10.1097/00007890-199705150-00015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.